Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2115-2120

  Milgraum, Lea Z ^b   Witters, Lee A ^c   Pasternack, Gary R ^a   Kuhajda, Francis P ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE;

ADULT; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYL-COA CARBOXYLASE; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS;

EID: 0030706079     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Isola, J., Visokorpi, T., Holli, K., and Kallioniemi, O. P. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. Natl. Cancer Inst. (Bethesda), 84: 1109-1114, 1992.
2. Thor, A. D., Moore, D. H., Edgerton, S. M., Kawasaki, S. M., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L. C., Mayall, B. H., and Smith. H. S. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. Natl. Cancer Inst. (Bethesda). 84: 845-855, 1992.
3. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990.
4. Allred, D. C., O'Connell, P., Fuqua, S. A. W., and Osborne, C. K. Immunohistochemical studies of early breast cancer evolution. Breast Cancer Res. Treat., 32: 13-18, 1994.
5. O'Malley, F. P., Vnencak-Jones, C. L., Dupont, W. D., Pari, F., Manning, S., and Page, D. L. p53 mutations are confined to the comedo-type ductal carcinoma in situ of the breast. Lab. Invest., 71: 67-72, 1994.
6. Eriksson, E. T., Schimmelpenning, H., Aspenblad, U., Zetterberg, A., and Auer, G. U. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Hum. Pathol. 25: 1228-1233, 1994.
7. Hardman, W., Gansler, T., Schaffei, S., and Hennigar, R. OA-519 immunostaining portends poor prognosis in ovarian cancer. Mod. Pathol., 8: 90A, 1995.
8. Pizer, E. S., Kurman, R. J., Pasternack, G. R., and Kuhajda, F. P. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int. J. Gynecol. Pathol., 16: 45-51, 1997.
9. Rashid, A., Pizer, E. S., Moga, M., Milgraum, L. Z., Zahurak, M., Pasternack, G. R., Kuhajda, F. P., and Hamilton, S. R. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am. J. Pathol., 150: 201-208, 1997.
10. Epstein, J. I., CarMichael, M., and Partin, A. W. OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate. Urology, 45: 81-86, 1995.
11. Jensen, V., Ladekari, M., Holm-Nielsen, P., Flemming, B. S., and Flemming, M. The prognostic value of oncogenic antigen 510 (OA519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. Br. J. Pathol., 776: 343-352, 1995.
12. Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C., and Tondo, U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer (Phila.), 77: 474-482, 1996.
13. Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick. J. D., and Pasternack, G. R. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. USA, 91: 6379-6383, 1994.
14. Witters, L. A., Widmor, J., King, A. N., Fassihi, K., and Kuhajda, F. P. Identification of human acetyl-CoA carboxylase isoforms in tissue and in breast cancer cells. Int. J. Biochem., 26: 589-594, 1994.
15. Pizer, E. S., Wood, F. D., Pasternack, G. R., and Kuhajda, F. P. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res., 56: 745-751, 1996.
16. Lopaschuk, G. D., Witters, L. A., Ito, T., Barr, R., and Barr, A. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J. Biol. Chem., 269: 25871-25878, 1994.
17. Page, D. L., and Anderson, T. J. Diagnostic Histopathology of the Breast, pp. 182-184. New York: Churchill-Livingstone, Inc., 1987.
18. Barritt, G. J. Communication within Animal Cells, pp. 157-191. Oxford: Oxford University Press, 1992.
19. Goodridge, A. G. Fatty acid synthesis in eucaryotes. In: D. E. Vance and J. Vance (eds.). Biochemistry of Lipids, Lipoproteins and Membranes, pp. 111-139. Amsterdam: Elsevier Science Publishers, B. V., 1991.
20. Pizer, E. S., Wood, F. D., Heine, H. S., Romantsev, F. E., Pasternack, G. R., and Kuhajda, F. P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res., 56: 1189-1193, 1996.